Report an error   

Submitted: 16 May 2007 Modified: 08 April 2013
HERDIN Record #: PCHRDPC040167

Early invasive versus early conservative strategy in the management of unstable angina and non-Q wave MI: A meta-analysis.

1 Benedict M Lazatin,
2 Federick C Cheng,
3 Marilou T De Jesus
Heart Institute - St. Luke's Medical Center


BACKGROUND: Unstable angina and non-Q wave myocardial infarction are increasingly common syndromes in clinical practice. Over the past years, there have been several large randomized trials, most of them including over 1000 patients and using modern baseline treatment with aspirin, unfractionated or low-molecular weight heparin, and recently glycoprotein IIb/IIIa inhibition and stenting. But despite all the advances, there is continued debate as to whether a routine, early invasive strategy involving coronary angiography followed by revascularization in suitable patients is superior to a conservative approach of maximum medical management and performance of coronary angiography / revascularization only when clinically indicated. This meta-analysis is undertaken to determine whether an early invasive or an early conservative strategy is better in the management of unstable angina and non-Q wave myocardial infarction

METHODS: This is a meta-analysis (odds ratio, confidence interval). The studies were identified by Medline search and from the Cochrane database from 1990-2002 using the following MeSH terms: unstable angina, non-Q wave myocardial infarction, treatment, invasive and conservative, and by reviewing reference lists and inquiring from experts, pharmaceutical companies and from Cardiology websites

RESULTS: Six randomized controlled trials were included in this meta-analysis namely: Thrombolysis in Myocardial Infarction (TIMI) IIIB, Veterans Affair Non-Q wave Infarction Strategies in Hospital (VANQWISH) trial, Fast Revascularization during Instability in Coronary Artery Disease (FRISC II), Randomized Intervention Treatment of Angina (RITA 3) trial, Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy (TACTICS-TIMI 18) trial and Value of First Day Coronary Angiography/Angioplasty in Evolving Non-ST Elevation Myocardial Infarction (VINO). Measurement of primary endpoints of myocardial infarction, death and myocardial infarction and/ or death were done with the combined Peto odds ratio as follows: 0.76 (0.65-0.89) for myocardial infarction, 0.97 (0.80-1.18) for death, and 0.84 (0.74-0.96) for MI and/or death. Hospital readmission was used as a secondary endpoint with OR of 0.57 (0.50.064)

CONCLUSION: The meta-analysis of these studies demonstrated a reduction in the primary endpoints of myocardial infarction and death and/or myocardial infarction in the early invasive group. Readmission was likewise significantly lower with the invasive group. (Author)

Publication Type:
Publication Sub Type:
Philippine Journal of Cardiology
Publication Date:
April-June 2003
Philippine Heart Association, Inc.
Philippine College of Cardiology

LocationCall NumberAvailable FormatAvailability
Philippine Council for Health Research and Development Library Box no. 43 Fulltext Print Format (Request Document)
1. Cannon C, et al. . "Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban" N Engl J Med 25, 1879-87, 2001
2. Wallentin L, . "Non-ST-elevation acute coronary syndrome: Fuel for the invasive strategy" Lancet , 738-39, 2002
3. "TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Qwave myocardial infarction " Circulation 89, 1545-56, 1994
4. Boden W, et al. . "Outcomes in patients with acute non-Qwave MI randomly assigned to an invasive compared with a conservative management strategy" N Engl J Med 25, 1785-91, 1998
5. "FRISC II Investigators. Outcome at 1 year arrer an invasive compared with a non-invasive strategy in unstable coronary artery disease: the FRISC II invasive randomized trial" Lancet 356, 9-15, 2000
6. Anderson HV, et al. . "One-year results of the thrombolysis in myocardial infarction (TIMI) IIIB Clinical Trial" J Am Coli Cardiol 7, 1643-50, 1995
7. Spacek R, , Widimsky P, et al . "Value of first day angiography/ angioplasty in evolving non-ST elevation myocardial infarction: An open multicenter randomized trial: The VINO study" Euro Heart J 23, 230-238, 2002
8. Braunwald E, , Antman EM, et al. . "ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. " J Am ColI Cardiol 36, 970-1062, 2000
9. Grande P, , Saunamaki K , et al. , Madsen JK, . "Danish muliiceJ:jter randomized study of invasive vs conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). Danish trial in acute myocardial infarction " Circulation 96, 748-55, 1997
10. Mahoney E, , Jurkovirz C, et al. . "Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial Infarction" JAMA 15, 1851-58, 2002
11. "FRISC II Investigators. Invasive compared with non-invasive treatment in unstable coronary artery disease: FRISC II prospective randomized multicentre study " Lancet 354, 708-714., 1999
12. Andrews TC, , Raby K, et al. . "Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease " Circulation 95, 324-28, 1997
13. Lagerqvist B, , Hausted S, et al. . "A long-term perspective on the protective effects of an early invasive strategy in unstable coronary artery disease" J Am ColI Cardiol , 1902-1 , December 0004-2002
14. Fox, KAA, , Poole-Wilson , et al. . "Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British heart foundation RITA 3 randomized trial" Lancet , 743-51, 2002
15. Solomon, D , et al. . "Use of risk stratification to identifY patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy" J Am ColI Cardiol 38, 970-976, 2001